PQA Pharmacy Performance Measures in Development
Pharmacy performance measures evaluate quality of pharmacies and assess pharmacist-provided care and pharmacy-based services. Pharmacy performance measures provide pharmacists the opportunity to demonstrate their contributions toward high-quality, patient-centered care.
PQA is developing a set of standard pharmacy performance measures that would be appropriate for pharmacy accountability, once assessed against standard measure criteria and endorsed by PQA membership.
Overview of Current Measure Development Work
PQA's Pharmacy Measure Development Action Plan guides the organization's continued work to build out a pharmacy measure set suitable for payer-pharmacy arrangements. It outlines next steps for developing measure concepts that were prioritized based on their feasibility and usability. PQA is launching three Technical Expert Panels (TEPs) to begin development of prioritized pharmacy measure concepts, including:
- Hemoglobin A1c Reporting and Blood Pressure Reporting (launching November 10, 2020)
- Proportion of Days Covered (PDC) Composite: Renin Angiotensin System Antagonists, Statins, and Diabetes medications (November 18, 2020)
- Antidepressant Medication Management (January 2021)
PQA aims to complete development of these concepts to have the measures available for use in early 2022. Additional TEPs to develop prioritized concepts will be launched in the future.
Resources and Updates
- PQA and CPF Bring Health Care Leaders Together to Prioritize Pharmacy Quality Measures for Development (February 4, 2021)
- PQA Update on Development of Pharmacy Measures: Pharmacy Measure Development Action Plan (November 10, 2020)
- Memo for the PQA Public Comment Period on PQA's Draft Pharmacy Measure Development Action Plan (Comment period occurred August 6-28, 2020)
- PQA Stakeholder Advisory Meeting on the Draft Pharmacy Measure Development Action Plan (Recording) (August 6, 2020)
- PQA Update on Development of Pharmacy Measures: The Pharmacy Measure Development Action Plan (July 21, 2020)
- PQA Endorses Three New Pharmacy Performance Measures (February 6, 2020)
- Summary description of three new pharmacy performance measures recommended for endorsement by PQA (includes key points, specifications for each measure, and a description of PQA's Measure Development Process) (December 18, 2019)
- PQA Update on Development of Pharmacy Measures (October 15, 2019)
- PQA Update on Development of Pharmacy Measures (September 26, 2019)
- Memo for the PQA Public Comment Period on PQA’s Proposed Standard Measure Set for Pharmacy Accountability in Value-Based Models (Comment period occurred August 22-September 6, 2019)
- PQA All-Member Webinar: Building Consensus on Measures for Plan-Pharmacy Agreements (Recording) (August 22, 2019)
- PQA Summary from Building Consensus on Measures for Plan-Pharmacy Agreements: A Workshop to Develop a Roadmap for Standard Quality Measures (July 31- August 1, 2019)
Questions about PQA’s pharmacy measure development should be directed to PQA’s Performance Measurement Team at [email protected].
|
